|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
8.570 +0.350 (+4.258%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 15.087% | 14.757% | 14.199% | 13.026% | 2.099% |
| ROAE (%) | 23.171% | 23.700% | 24.397% | 23.670% | 3.846% |
| Return on Capital Employed (%) | 19.550% | 19.281% | 19.638% | 19.049% | 3.310% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 74.193% | 75.349% | 74.699% | 75.402% | 72.987% |
| EBITDA Margin (%) | 34.521% | 33.392% | 36.314% | 37.028% | 12.676% |
| Pre-tax Profit Margin (%) | 33.346% | 31.902% | 34.033% | 33.302% | 7.734% |
| Net Profit Margin (%) | 30.290% | 29.188% | 28.864% | 28.456% | 4.619% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.862 X | 2.682 X | 2.251 X | 1.996 X | 1.859 X |
| Quick Ratio (X) | 2.616 X | 2.478 X | 2.072 X | 1.826 X | 1.696 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 28.854% | 29.707% | 33.281% | 36.295% | 37.791% |
| Total Debt / Total Assets (%) | 9.287% | 9.406% | 14.004% | 13.908% | 14.929% |
| Net Debt / Total Assets (%) | -40.609% | -40.675% | -36.338% | -35.209% | -22.374% |
| Total Debt / Shareholders' Funds (%) | 14.105% | 14.631% | 23.340% | 24.744% | 27.760% |
| Long Term Debt / Shareholders' Funds (%) | 0.107% | 0.189% | 0.327% | 0% | 0% |
| Net Debt / Shareholders' Funds (%) | -61.677% | -63.272% | -60.563% | -62.641% | -41.606% |
| Net Cash / (Debt) ($) | 2.237B | 1.990B | 1.585B | 1.391B | 829.665M |
| Net Cash / (Debt) per share ($) | 2.758 | 2.466 | 1.923 | 1.697 | 0.959 |
| Total Debt / Capital Employed (%) | 12.747% | 12.992% | 20.330% | 20.983% | 22.953% |
| Interest Coverage Ratio (X) | 41.618 X | 69.270 X | 54.922 X | 28.276 X | 6.714 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 175.601 Day | 164.266 Day | 165.949 Day | 185.420 Day | 164.574 Day |
| Receivables Turnover (Day) | 36.315 Day | 47.643 Day | 71.385 Day | 126.226 Day | 171.892 Day |
| Payables Turnover (Day) | 10.075 Day | 9.870 Day | 10.490 Day | 11.079 Day | 15.658 Day |
| Remarks: | Real time quote last updated: 25/11/2024 16:58 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 399,765 |
| %Change | 14.910% |
| EPS / (LPS) | RMB 0.499 |
| NBV Per Share (¥) | RMB 4.383 |